未知股票 NOVN 深 沪
已收盘
--
0.000
NaN.00%
华盛通- 最 高--
- 今 开--
- 成交量 --
- 最 低 --
- 昨 收 --
- 总市值 0
- 52周最高 --
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 --
- 委 比 0.00%
- 总股本 2801.54万
- 历史最高 --
- 量 比 0
- 振 幅 NaN.00%
- 历史最低 --
- 每 手 1
- 风险率 0.66%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BREAKINGVIEWS-Novo Nordisk’s falling knife is still gathering speed
BREAKINGVIEWS-Novo Nordisk’s falling knife is still gathering speed The author is a Reuters Breakingviews columnist. The opinions expressed are her own. By Aimee Donnellan DUBLIN, Feb 4 (Reuters Breakingviews) - Ozempic and the other progeny of weight loss drugs offer users the promise of an end to
02-04 18:26
BRIEF-Novartis CEO: "It's Early Days" For Any Change In European Drug Pricing Due To MFN
BRIEF-Novartis CEO: "It's Early Days" For Any Change In European Drug Pricing Due To MFN Feb 4 (Reuters) - Novartis AG NOVN.S : NOVARTIS CEO SAYS US MOST-FAVORED-NATION REGULATION NOT HAVING A MATERIAL EFFECT ON OUR 2026 GUIDANCE NOVARTIS CEO SAYS AGREEMENT ON US DRUG PRICES IS INCLUDED IN OUR MID-T
02-04 15:00
UPDATE 1-Novartis expects low single-digit decline in 2026 operating profit
UPDATE 1-Novartis expects low single-digit decline in 2026 operating profit Adds Q4 results, background FRANKFURT, Feb 4 (Reuters) - Swiss drugmaker Novartis NOVN.S forecast a decline in 2026 operating profit in the low single-digit percentage range on Wednesday, held back by competition from cheape
02-04 14:21
Novartis expects low single-digit decline in 2026 operating profit
Novartis expects low single-digit decline in 2026 operating profit FRANKFURT, Feb 4 (Reuters) - Swiss drugmaker Novartis NOVN.S forecast a decline in 2026 operating profit in the low single-digit percentage range on Wednesday, held back by competition from cheaper copies of established products such
02-04 14:10
FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms
FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms Changes dateline, adds Eli Lilly details in paragraph 11 Jan 30 (Reuters) - Global drugmakers are ramping up U.S. manufacturing and stockpiling inventory as the Trump administration considers a 100% tariff on imported branded
01-30 20:07
Biotech Inventiva's 50% surge shows investor optimism over liver disease drug
Biotech Inventiva's 50% surge shows investor optimism over liver disease drug Inventiva shares up 50% in January Optimism builds around its MASH drug Big Pharma signal strategic interest A lot riding out Phase 3 outcome Evaluating funding options, CEO tells Reuters By Danilo Masoni MILAN, Jan 28 (Re
01-28 23:36
UPDATE 2-US names HIV, arthritis drugs for next Medicare price talks
UPDATE 2-US names HIV, arthritis drugs for next Medicare price talks Recasts first sentence with Gilead, adds details throughout on drugs, analyst comment, share prices, trade group comments, company comments Fifteen drugs targeted for Medicare price negotiations in 2028 Industry opposes law, citing
01-28 06:29
FOCUS-Drugmakers turn to AI to speed trials, regulatory submissions
FOCUS-Drugmakers turn to AI to speed trials, regulatory submissions Pharmaceutical companies describe AI benefits for tedious work Novartis says AI cut trial site selection from weeks to a two-hour meeting Drugmakers use AI to draft regulator-ready filings By Maggie Fick and Michael Erman SAN FRANCI
01-26 19:00
Novanta CFO Robert Buckley Reports Sale of Common Shares
Novanta CFO Robert Buckley Reports Sale of Common Shares Robert Buckley, Chief Financial Officer of Novanta Inc., reported a disposal of common shares of Novanta Inc., according to a recent SEC filing. The full filing can be accessed through the link below. Disclaimer: This news brief was created by
01-24 05:17
Novanta CEO Matthijs Glastra Reports Sale of Common Shares
Novanta CEO Matthijs Glastra Reports Sale of Common Shares Matthijs Glastra, Chief Executive Officer and Director of Novanta Inc., reported a disposal of common shares of Novanta Inc. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologi
01-24 05:14
